Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.79
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 22, with a low estimate of 15 and a high estimate of 36. The average target predicts an increase of 224.01% from the current stock price of 6.79.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2025.
Analyst Ratings
The average analyst rating for Wave Life Sciences stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +224.01% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +224.01% | Mar 5, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +282.92% | Feb 25, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | +224.01% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +224.01% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
70.82M
from 108.30M
Decreased by -34.61%
Revenue Next Year
69.95M
from 70.82M
Decreased by -1.23%
EPS This Year
-1.00
from -0.70
EPS Next Year
-1.06
from -1.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.1M | 138.7M | 402.2M | ||
| Avg | 70.8M | 70.0M | 167.4M | ||
| Low | 34.3M | n/a | 32.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.1% | 95.8% | 474.9% | ||
| Avg | -34.6% | -1.2% | 139.3% | ||
| Low | -68.3% | - | -53.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.67 | -0.64 | 0.26 | ||
| Avg | -1.00 | -1.06 | -0.67 | ||
| Low | -1.30 | -1.41 | -1.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.